ADHD
11.5% of Biodyne acquired by technology company
Published in Drug Week, October 8th, 2004
Biodyne Inc. is a Houston-based, privately held, biomedical development firm, and has engaged Biodyne in the development and implementation of its clinical neurotherapy services to be delivered by Qbit's subsidiary, Physical Therapy Associates, later this year. The initial focus for these therapies is the treatment of attention deficit disorder (ADD), thus providing an alternate to treatment with psycho-stimulants such as Ritalin. A quote from a recent scientific animal study points to the potential negative effects of the extensive use of the psycho-stimulant, Ritalin, to treat attention...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-10-08)
More Articles from Drug Week
- ADHD
FDA approves Methylin Chewable Tablets, Methylin Oral Solution for ADHD - Breast Cancer
Hedgehog signaling pathway is new therapeutic target for breast cancer - Metabolic Syndrome
New data presented for Crestor in patients with metabolic syndrome - Smallpox
FDA clears IND for an attenuated smallpox vaccine candidate - Tremor
Agilect reduced tremor and severity of "off" time in Parkinson patients - ADHD
Atomoxetine is novel treatment for attention deficit-hyperactivity disorder - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
